longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Why This Top-Notch Trio Of Biotech Stocks Just Took A Tumble

Unusual Whales
Aug 3, 2026 at 03:02 PM
Leading biotech companies TG Therapeutics and Twist Bioscience experienced significant declines on Monday following the release of their second-quarter reports. The stocks of these top-performing companies dropped due to mixed results. The sudden fall in value has raised concerns among investors, as these companies were previously considered top-notch in the biotech sector.

Source: Unusual Whales The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Related Stocks

TG Therap

TG Therap

USTGTX

-1.78%

Twist Bioscience

Twist Bioscience

USTWST

+2.49%

LongbridgeAI